© 1997 by Oxford University Press
Journal Of The National Cancer Institute, Vol 89, 1683-1691, Copyright © 1997 by Oxford University Press
AL Potosky, RM Merrill, GF Riley, SH Taplin, W Barlow, BH Fireman and R Ballard- Barbash
BACKGROUND: Enrollment in health maintenance organizations (HMOs) has
increased rapidly during the past 10 years, reflecting a growing emphasis
on health care cost containment. To determine whether there is a difference
in the treatment and outcome for female patients with breast cancer
enrolled in HMOs versus a fee-for-service setting, we compared the 10-year
survival and initial treatment of patients with breast cancer enrolled in
both types of plans. METHODS: With the use of tumor registries covering the
greater San Francisco-Oakland and Seattle- Puget Sound areas, respectively,
we obtained information on the treatment and outcome for 13,358 female
patients with breast cancer, aged 65 years and older, diagnosed between
1985 and 1992. We linked registry information with Medicare data and data
from the two large HMOs included in the study. We compared the survival and
treatment differences between HMO and fee-for-service care after adjusting
for tumor stage, comorbidity, and sociodemographic characteristics.
RESULTS: In San Francisco-Oakland, the 10-year adjusted risk ratio for
breast cancer deaths among HMO patients compared with fee-for-service
patients was 0.71 (95% confidence interval [CI] = 0.59-0.87) and was
comparable for all deaths. In Seattle-Puget Sound, the risk ratio for
breast cancer deaths was 1.01 (95% CI = 0.77-1.33) but somewhat lower for
all deaths. Women enrolled in HMOs were more likely to receive
breast-conserving surgery than women in fee-for-service (odds ratio = 1.55
in San Francisco-Oakland; 3.39 in Seattle). HMO enrollees undergoing
breast-conserving surgery were also more likely to receive adjuvant
radiotherapy (San Francisco-Oakland odds ratio = 2.49; Seattle odds ratio =
4.62). CONCLUSIONS: Long-term survival outcomes in the two prepaid group
practice HMOs in this study were at least equal to, and possibly better
than, outcomes in the fee-for-service system. In addition, the use of
recommended therapy for early stage breast cancer was more frequent in the
two HMOs.
ARTICLES
Breast cancer survival and treatment in health maintenance organization and fee-for-service settings
Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD 20892-7344, USA. potosky@nih.gov
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. M. Swetter, S. Soon, C. R. Harrington, and S. C. Chen Effect of Health Care Delivery Models on Melanoma Thickness and Stage in a University-Based Referral Center: An Observational Pilot Study Arch Dermatol, January 1, 2007; 143(1): 30 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Xu and G. A. Jensen Health Effects of Managed Care Among the Near-Elderly J Aging Health, August 1, 2006; 18(4): 507 - 533. [Abstract] [PDF] |
||||
![]() |
R. S. Kirsner, F. Ma, L. Fleming, D. G. Federman, E. Trapido, R. Duncan, and J. D. Wilkinson The effect of medicare health care delivery systems on survival for patients with breast and colorectal cancer. Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 769 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Buchholz, R. L. Theriault, J. C. Niland, M. E. Hughes, R. Ottesen, S. B. Edge, M. A. Bookman, and J. C. Weeks The Use of Radiation As a Component of Breast Conservation Therapy in National Comprehensive Cancer Network Centers J. Clin. Oncol., January 20, 2006; 24(3): 361 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Woods, B. Rachet, and M. P. Coleman Origins of socio-economic inequalities in cancer survival: a review Ann. Onc., January 1, 2006; 17(1): 5 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Edwards, M. L. Brown, P. A. Wingo, H. L. Howe, E. Ward, L. A. G. Ries, D. Schrag, P. M. Jamison, A. Jemal, X. C. Wu, et al. Annual Report to the Nation on the Status of Cancer, 1975-2002, Featuring Population-Based Trends in Cancer Treatment J Natl Cancer Inst, October 5, 2005; 97(19): 1407 - 1427. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Elmore, L. M. Reisch, M. B. Barton, W. E. Barlow, S. Rolnick, E. L. Harris, L. J. Herrinton, A. M. Geiger, R. K. Beverly, G. Hart, et al. Efficacy of Breast Cancer Screening in the Community According to Risk Level J Natl Cancer Inst, July 20, 2005; 97(14): 1035 - 1043. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Herrinton, W. E. Barlow, O. Yu, A. M. Geiger, J. G. Elmore, M. B. Barton, E. L. Harris, S. Rolnick, R. Pardee, G. Husson, et al. Efficacy of Prophylactic Mastectomy in Women With Unilateral Breast Cancer: A Cancer Research Network Project J. Clin. Oncol., July 1, 2005; 23(19): 4275 - 4286. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Stark, G. Kucera, M. Lu, S. Claud, and J. Griggs Influence of health insurance status on inclusion of HER-2/neu testing in the diagnostic workup of breast cancer patients Int. J. Qual. Health Care, December 1, 2004; 16(6): 517 - 521. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Mandelblatt, C. B. Schechter, K. R. Yabroff, W. Lawrence, J. Dignam, P. Muennig, Y. Chavez, J. Cullen, and M. Fahs Benefits and Costs of Interventions to Improve Breast Cancer Outcomes in African American Women J. Clin. Oncol., July 1, 2004; 22(13): 2554 - 2566. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Morrow, M. Siegel, S. Boone, G. Lawless, and W. Carter Chemotherapy Dose Intensity Determination as a Quality of Care Measure for Managed Care Organizations in the Treatment of Early-Stage Breast Cancer American Journal of Medical Quality, November 1, 2002; 17(6): 218 - 224. [Abstract] [PDF] |
||||
![]() |
M. L. Pearson, P. A. Ganz, K. McGuigan, J. R. Malin, J. Adams, and K. L. Kahn The Case Identification Challenge in Measuring Quality of Cancer Care J. Clin. Oncol., November 1, 2002; 20(21): 4353 - 4360. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Malin, M. A. Schuster, K. A. Kahn, and R. H. Brook Quality of Breast Cancer Care: What Do We Know? J. Clin. Oncol., November 1, 2002; 20(21): 4381 - 4393. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Miller and H. S. Luft HMO Plan Performance Update: An Analysis Of The Literature, 1997-2001 Health Aff., July 1, 2002; 21(4): 63 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Malin, K. L. Kahn, J. Adams, L. Kwan, M. Laouri, and P. A. Ganz Validity of Cancer Registry Data for Measuring the Quality of Breast Cancer Care J Natl Cancer Inst, June 5, 2002; 94(11): 835 - 844. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Warren, M. L. Brown, M. P. Fay, N. Schussler, A. L. Potosky, and G. F. Riley Costs of Treatment for Elderly Women With Early-Stage Breast Cancer in Fee-for-Service Settings J. Clin. Oncol., January 1, 2002; 20(1): 307 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Fireman, L. Fehrenbacher, E. P. Gruskin, and G. T. Ray Cost of Care for Patients in Cancer Clinical Trials J Natl Cancer Inst, January 19, 2000; 92(2): 136 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Roetzheim, N. Pal, C. Tennant, L. Voti, J. Z. Ayanian, A. Schwabe, and J. P. Krischer Effects of Health Insurance and Race on Early Detection of Cancer J Natl Cancer Inst, August 18, 1999; 91(16): 1409 - 1415. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Merrill, M. L. Brown, A. L. Potosky, G. Riley, S. H. Taplin, W. Barlow, and B. H. Fireman Survival and Treatment for Colorectal Cancer Medicare Patients in Two Group/Staff Health Maintenance Organizations and the Fee-for-Service Setting Med Care Res Rev, June 1, 1999; 56(2): 177 - 196. [Abstract] [PDF] |
||||
![]() |
G. F. Riley, A. L. Potosky, C. N. Klabunde, J. L. Warren, and R. Ballard-Barbash Stage at Diagnosis and Treatment Patterns Among Older Women With Breast Cancer: An HMO and Fee-for-Service Comparison JAMA, February 24, 1999; 281(8): 720 - 726. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Hillner and T. J. Smith Hospital Volume and Patient Outcomes in Major Cancer Surgery: A Catalyst for Quality Assessment and Concentration of Cancer Services JAMA, November 25, 1998; 280(20): 1783 - 1785. [Full Text] [PDF] |
||||










